Alpha-synuclein pathology and Parkinson’s disease-related olfactory dysfunctions: an update on preclinical models and therapeutic approaches
Mammalian Genome · 2025-06 · 36 (2) · 444-464
DOI: 10.1007/s00335-025-10128-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mammalian Genome, online erschienen am 28.04.2025. Verfasst von Jancy Nixon Abraham und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neural Circuits and Behaviour (LNCB), Department of Biology, Indian Institute of Science Education and Research (IISER), Pune, Maharash…. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease, Olfaction Disorders. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 246 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Govt. of India, DBT-Wellcome Trust India Alliance, Wellcome Trust DBT India Alliance.
Abstract (Originalsprache)
Olfactory dysfunction (OD) is considered one of the early signs of Parkinson's disease (PD), affecting over 90% of PD patients. OD often appears several years before the onset of motor symptoms and is therefore considered an early biomarker of PD. Recent studies have shown that COVID-19 infection might lead to worsening of symptoms and acceleration of disease progression in neurodegenerative disorders, where OD is a common symptom to both. Hence, it is essential to accurately monitor olfactory fitness in clinical settings using any of the currently available olfactory function tests. Even after a quarter of a century of the discovery of α-synuclein (α-syn) pathogenesis in PD, many aspects related to the α-syn pathogenesis in OD remain unknown. Currently, there is no definitive cure for PD; the disease management options include dopaminergic medications, deep brain stimulations, stem cells, and immunotherapy. Generating reliable PD animal models is critical for understanding the molecular pathways and neural circuits affected by disease conditions. This might contribute to the development and validation of new therapeutic approaches. This review discusses the known mechanisms of α-syn aggregated forms causing neuronal death, the recent developments in the PD preclinical models with ODs, and the treatment strategies employed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Neural Circuits and Behaviour (LNCB), Department of Biology, Indian Institute of Science Education and Research (IISER), Pune, Maharashtra, 411008, India. jancysara@gmail.com.
- Department of Life Sciences, Centre of Excellence in Epigenetics, Shiv Nadar Institution of Eminence, Gautam Buddha Nagar, Greater Noida, Uttar Pradesh, 201314, India. jancysara@gmail.com.
- Laboratory of Neural Circuits and Behaviour (LNCB), Department of Biology, Indian Institute of Science Education and Research (IISER), Pune, Maharashtra, 411008, India.
- Laboratory of Neural Circuits and Behaviour (LNCB), Department of Biology, Indian Institute of Science Education and Research (IISER), Pune, Maharashtra, 411008, India. nabraham@iiserpune.ac.in.
Förderung
- Govt. of India
- DBT-Wellcome Trust India Alliance
- Wellcome Trust DBT India Alliance
- Department of Biotechnology, Ministry of Science and Technology, India
- DBT/Wellcome Trust India Alliance Intermediate grant
- University Grants Commission
Zitieren
APA
Abraham, J. N., Rawat, D., Srikanth, P., Sunny, L. P., & Abraham, N. M. (2025). Alpha-synuclein pathology and Parkinson’s disease-related olfactory dysfunctions: an update on preclinical models and therapeutic approaches. Mammalian Genome, 36(2), 444-464. https://doi.org/10.1007/s00335-025-10128-w
Vancouver
Abraham JN, Rawat D, Srikanth P, Sunny LP, Abraham NM. Alpha-synuclein pathology and Parkinson’s disease-related olfactory dysfunctions: an update on preclinical models and therapeutic approaches. Mammalian Genome. 2025;36(2):444-464. doi:10.1007/s00335-025-10128-w
BibTeX
@article{Abraham2025,
author = {Abraham, Jancy Nixon and Rawat, Devesh and Srikanth, Priyadharshini and Sunny, Lisni P and Abraham, Nixon M},
title = {Alpha-synuclein pathology and Parkinson’s disease-related olfactory dysfunctions: an update on preclinical models and therapeutic approaches},
journal = {Mammalian Genome},
year = {2025},
volume = {36},
number = {2},
pages = {444--464},
doi = {10.1007/s00335-025-10128-w}
}
EUVIMED